Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Dec 24:17:11795476241307123.
doi: 10.1177/11795476241307123. eCollection 2024.

Immune-Complex Mediated Mesangial Proliferative Glomerulonephritis with Full-House Pattern Observed During Treatment of Immune Thrombocytopenic Purpura

Affiliations
Case Reports

Immune-Complex Mediated Mesangial Proliferative Glomerulonephritis with Full-House Pattern Observed During Treatment of Immune Thrombocytopenic Purpura

Ai Ueki et al. Clin Med Insights Case Rep. .

Abstract

This study reports a rare case of immune-complex mediated mesangial proliferative glomerulonephritis (ICGN) with a full-house pattern in a 56-year-old Japanese man, observed during the treatment of immune thrombocytopenic purpura (ITP). Because of persistent complement deficiency and worsening of kidney function, he was treated with prednisolone, and his urinary findings improved markedly. However, as the complement titers were still low, mycophenolate mofetil was also prescribed, which normalized complement levels. Production of anti-platelet antibodies is considered to be involved in the etiology of ITP. Although little is known about the mechanism by which ITP causes glomerulonephritis, including ICGN, glomerular deposition of circulating immune complexes synthesized by antiplatelet antibodies may be involved. This case shows full-house nephropathy, suggesting the involvement of immune complexes, which in turn, suggested an association between ITP and glomerulonephritis.

Keywords: Immune-complex mediated mesangial proliferative glomerulonephritis; full-house nephropathy; immune thrombocytopenic purpura; membranoproliferative glomerulonephritis; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Representative light microscopy and electron microscopy on kidney biopsy specimen: (a) mesangial hypercellularity (arrow) by light microscope (periodic acid-Schiff staining, ×400), (b) total circumferential thickening of glomerular basement membrane (arrow) by light microscope (periodic acid-Schiff staining, ×400), (c) electron-dense deposits (EDD) in the mesangial region (arrow) by electron microscope (×1500), and (d) EDD in the subendothelial region (arrow) by electron microscope (×1000). Granular IgG, IgA, IgM, C3, C4, and C1q deposit in the mesangial region. Fibrinogen is negative.
Figure 2.
Figure 2.
Immunohistochemistry of the glomerulus (immunofluorescence staining, ×400). Granular IgG, IgA, IgM, C3, C4, and C1q deposit in the mesangial region. Fibrinogen is negative.
Figure 3.
Figure 3.
Clinical course of the patient after the initiation of treatment for membranoproliferative glomerulonephritis. Abbreviations: Cr, creatinine; PSL, prednisolone.

Similar articles

References

    1. Kashiwagi H, Kuwana M, Hato T, et al.. Reference guide for management of adult immune thrombocytopenia in Japan: 2019 revision. Int J Hematol. 2020;111:329-351. - PMC - PubMed
    1. Kahraman C, Emre H, Gulcan E, et al.. Combined immune thrombocytopenic purpura and immunoglobulin A nephropathy: a similar pathophysiologic process? Ren Fail. 2014;36:464-465. - PubMed
    1. Yehudai D, Toubi E, Shoenfeld Y, Vadasz Z. Autoimmunity and novel therapies in immune-mediated thrombocytopenia. Semin Hematol. 2013;50:S100-S108. - PubMed
    1. Lande MB, Thomas GA, Houghton DC. Membranous nephropathy associated with chronic immune thrombocytopenic purpura in childhood. Am J Kidney Dis. 2001;37:E40. - PubMed
    1. Zheng SS, Ahmadi Z, Leung HH, et al.. Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia. Haematologica. 2022;107:2195-2205. - PMC - PubMed

Publication types

LinkOut - more resources